Search by Drug Name or NDC

    NDC 51079-0926-20 Diltiazem Hydrochloride 120 mg/1 Details

    Diltiazem Hydrochloride 120 mg/1

    Diltiazem Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is DILTIAZEM HYDROCHLORIDE.

    Product Information

    NDC 51079-0926
    Product ID 51079-926_f838a986-bd2f-16bd-e053-6294a90a0395
    Associated GPIs 34000010106920
    GCN Sequence Number 000570
    GCN Sequence Number Description diltiazem HCl CAP ER 12H 120 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02321
    HICL Sequence Number 000182
    HICL Sequence Number Description DILTIAZEM HCL
    Brand/Generic Generic
    Proprietary Name Diltiazem Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name diltiazem hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 120
    Active Ingredient Units mg/1
    Substance Name DILTIAZEM HYDROCHLORIDE
    Labeler Name Mylan Institutional Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074910
    Listing Certified Through 2024-12-31

    Package

    NDC 51079-0926-20 (51079092620)

    NDC Package Code 51079-926-20
    Billing NDC 51079092620
    Package 100 BLISTER PACK in 1 CARTON (51079-926-20) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (51079-926-01)
    Marketing Start Date 1999-12-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.5045
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DILTIAZEM 12HR ER 120 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis